A world-first clinical trial will examine whether an everyday antibiotic could help reduce recurrent miscarriages.
Hope that a common antibiotic could end the heartbreak of recurrent miscarriages
In a world-first trial, University of Warwick researchers will test doxycycline on around 3,000 women at NHS hospitals.
In the US and Germany, the drug is already used to treat recurrent miscarriage by improving the balance of bacteria in the reproductive system.
Scientists hope it will result in a potential new test and treatment for the condition which could help up to half of women who suffer recurrent miscarriages.
1 in 100 women experience recurrent miscarriages in the UK each year.
Warwick Medical School’s Professor Siobhan Quenby, the principal investigator on the trial, said: “This is potentially a new treatment for up to half of people with recurrent miscarriage.
“We know that doxycycline is given to some women experiencing a miscarriage in other countries, but there has never been a proper trial conducted.
“And instead of just having your blood tested to look for causes of miscarriage, as is current practice, you will have the lining of the womb tested too so that we can identify those who will benefit from this treatment.